Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.31 |
| ▸ | TET3 | O43151 | 1/20 | 0.31 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7714154 | 0.79 | TDP1 (0.38) | ALOX15HSD17B10 | |
| Itaconate SCHEMBL27534510 | 0.74 | ALOX15 (0.48) | ALOX15HSD17B10 | |
| Itaconate SCHEMBL7044038 | 0.71 | ALOX15 (0.46) | ALOX15HSD17B10 | |
| Itaconate SCHEMBL27584099 | 0.71 | ALOX15 (0.68) | ALOX15HSD17B10TET2TET3TET1 | |
| Itaconate SCHEMBL29886131 | 0.70 | — | — | |
| Itaconate SCHEMBL286967 | 0.70 | ALOX15 (0.75) | ALOX15HSD17B10TET2TET3TET1 | |
| Itaconate SCHEMBL21523 | 0.70 | — | — | |
| SCHEMBL12808169 | 0.70 | — | — | |
| SCHEMBL1809603 | 0.69 | ALOX15 (0.57) | ALOX15HSD17B10TET2TET3TET1 | |
| SCHEMBL643273 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11045833-B2 | Task specific ionic liquid-impregnated polymeric surface coatings for antibacterial, antifouling, and metal scavenging activity | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-29 | — | — | US | disclosed |
| US-9273354-B2 | System and apparatus for sequential processing of analytes | ILLUMINA, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| CN-104398496-A | Once-a-day replacement transdermal administration of fentanyl | ALZA CORP | 2015-03-11 | — | — | CN | disclosed |
| CN-101902996-B | Once-a-day replacement transdermal administration of fentanyl | ALZA CORP | 2014-11-26 | — | — | CN | disclosed |
| US-20140213464-A1 | SYSTEM AND APPARATUS FOR SEQUENTIAL PROCESSING OF ANALYTES | ILLUMINA, INC. (US) | 2014-07-31 | — | — | US | disclosed |
| US-8728729-B2 | Method for sequential sequencing nucleic acids | ILLUMINA, INC. (US) | 2014-05-20 | — | — | US | disclosed |
| US-20130184162-A1 | SYSTEM AND APPARATUS FOR SEQUENTIAL PROCESSING OF ANALYTES | ILLUMINA, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| CN-101351335-B | Multilayer fluoropolymer films | ARKEMA INC | 2013-05-15 | — | — | CN | disclosed |
| US-8361713-B2 | System and apparatus for sequential processing of analytes | ILLUMINA, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| CN-101902996-A | Once-a-day replacement transdermal administration of fentanyl | ALZA CORP | 2010-12-01 | — | — | CN | disclosed |
| US-6406848-B1 | MICROPARTICLES AND POLYNUCLEOTIDES | LYNX THERAPEUTICS, INC. | 2002-06-18 | — | — | US | disclosed |
| US-20020061529-A1 | System and apparatus for sequential processing of analytes | LYNX THERAPEUTICS, INC. (US) | 2002-05-23 | — | — | US | disclosed |
| US-20020051992-A1 | Device for the analysis and monitoring of multiple samples on a solid support | LYNX THERAPEUTICS, INC. (US) | 2002-05-02 | — | — | US | disclosed |
| EP-1017847-A1 | METHOD OF MAPPING RESTRICTION SITES IN POLYNUCLEOTIDES | LYNX THERAPEUTICS, INC. (US) | 2000-07-12 | — | — | EP | disclosed |
| EP-0985142-A2 | SYSTEM AND APPARAUS FOR SEQUENTIAL PROCESSING OF ANALYTES | LYNX THERAPEUTICS, INC. (US) | 2000-03-15 | — | — | EP | disclosed |
| CN-1230226-A | Sequencing by ligation of encoded adaptors | LYNX THERAPEUTICS INC (US) | 1999-09-29 | — | — | CN | disclosed |
| EP-0923650-A1 | SEQUENCING BY LIGATION OF ENCODED ADAPTORS | LYNX THERAPEUTICS, INC. (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1999000519-A1 | METHOD OF MAPPING RESTRICTION SITES IN POLYNUCLEOTIDES | LYNX THERAPEUTICS, INC. (US) | 1999-01-07 | — | — | WO | disclosed |
| WO-1998053300-A2 | SYSTEM AND APPARAUS FOR SEQUENTIAL PROCESSING OF ANALYTES | LYNX THERAPEUTICS, INC. (US) | 1998-11-26 | — | — | WO | disclosed |
| WO-1997046704-A1 | SEQUENCING BY LIGATION OF ENCODED ADAPTORS | LYNX THERAPEUTICS, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045833-B2 | Task specific ionic liquid-impregnated polymeric surface coatings for antibacterial, antifouling, and metal scavenging activity | LPO, SOD1, ICMT | ALOX15 49/4885HSD17B10 811/4885TET2 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.